Faculty Coordinators:
David Scadden, MD (MGH)
Jerome Ritz, MD (DFCI)

Mesenchymal stem cells are touted to be everything but shoe polish.  They may be biosmart delivery vehicles for complex protein combinations or just biologic debris, but they are the subject of much activity in both academic and industrial biomedicine.  Come hear colleagues provide their perspective from both the academic and corporate side and engage in the debate about where this field should go.

Discussants include:

Review of GvHD data
Robert Soiffer, MD
Professor of Medicine, Harvard Medical School
Chief, Division of Hematologic Malignancies and
Co-director, Adult Stem Cell Transplantation Program
DFCI

Cardiovascular applications
Richard T. Lee, MD (BWH)
Principal Faculty, HSCI

Assessment of the field from a commercial perspective
Ruth McKernan, PhD
Chief Scientific Officer
Pfizer Regenerative Medicine

Refreshments will be available.